NCT04065295View on ClinicalTrials.gov

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

December 23, 2019

Study Completion Date

December 23, 2019

Conditions
Healthy
Interventions
DRUG

BI 1356225

Oral Dose

DRUG

Placebo

Oral dose

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 | Biotech Hunter | Biotech Hunter